Overview of Metabolite Safety Testing from an Industry Perspective
- 13 July 2010
- journal article
- review article
- Published by Taylor & Francis in Bioanalysis
- Vol. 2 (7) , 1249-1261
Abstract
Regulatory guidelines on MIST were initially established in 2005 and finalized in 2008 by the US FDA and this has led to much discussion and debate on how to apply these recommendations in today's resource-constrained pharmaceutical environment. There are four aspects of MIST that impact on the field of bioanalysis: definition of a disproportionate human metabolite, establishment of nonclinical (animal) safety coverage for important human metabolites, degree of rigor in validation of bioanalytical methods to quantify metabolites when synthetic standards are available, and semiquantitation of metabolites when synthetic standards are not available. In this manuscript, each of these points has been addressed from a pharmaceutical industry standpoint, including a perspective on the necessary convergence of the fields of metabolite safety testing and bioanalysis.Keywords
This publication has 39 references indexed in Scilit:
- Predicting Circulating Human Metabolites: How Good Are We?Chemical Research in Toxicology, 2009
- CURRENT OPINION: SAFETY EVALUATION OF DRUG METABOLITES IN DEVELOPMENT OF PHARMACEUTICALSThe Journal of Toxicological Sciences, 2007
- Complicating factors in safety testing of drug metabolites: Kinetic differences between generated and preformed metabolitesToxicology and Applied Pharmacology, 2006
- Safety Assessment of Drug Metabolites: Characterization of Chemically Stable MetabolitesChemical Research in Toxicology, 2006
- A Regulatory Perspective on Issues and Approaches in Characterizing Human MetabolitesChemical Research in Toxicology, 2006
- Safety Assessment of Stable Drug MetabolitesChemical Research in Toxicology, 2006
- Metabolites and Safety: What Are the Concerns, and How Should We Address Them?Chemical Research in Toxicology, 2006
- ReplyToxicology and Applied Pharmacology, 2003
- Letter to the EditorToxicology and Applied Pharmacology, 2003
- Drug Metabolites in Safety TestingToxicology and Applied Pharmacology, 2002